NCT02444221View on ClinicalTrials.gov

Rivaroxaban Evaluation in Real Life Settings

CompletedOBSERVATIONAL
Enrollment

5,278

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

May 30, 2019

Study Completion Date

September 30, 2020

Conditions
Atrial FibrillationStroke
Trial Locations (2)

Unknown

Prof. Jean-Yues LeHeuzey, National Coordinating Investigator, Hopital Europeen Georges Pompidou, Paris

SW3 6LR

Thrombosis Research Institute, London

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Thrombosis Research Institute

OTHER